Home › Compare › PEAR vs PLD

PEAR vs PLD: Dividend Comparison 2026

PEAR yields 6849.32% · PLD yields 3.18%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PEAR wins by $1339387406433207.25M in total portfolio value
10 years
PEAR
PEAR
● Live price
6849.32%
Share price
$0.03
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1339387406433213.75M
Annual income
$1,301,993,616,197,644,700,000.00
Full PEAR calculator →
PLD
PLD
● Live price
3.18%
Share price
$128.78
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.50M
Annual income
$5,256,436.18
Full PLD calculator →

Portfolio growth — PEAR vs PLD

📍 PEAR pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPEARPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PEAR + PLD cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
PEAR pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PEAR
Annual income on $10K today (after 15% tax)
$582,191.78/yr
After 10yr DRIP, annual income (after tax)
$1,106,694,573,767,997,900,000.00/yr
PLD
Annual income on $10K today (after 15% tax)
$270.62/yr
After 10yr DRIP, annual income (after tax)
$4,467,970.75/yr
At 15% tax rate, PEAR beats the other by $1,106,694,573,767,993,500,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PEAR + PLD for your $10,000?

PEAR: 50%PLD: 50%
100% PLD50/50100% PEAR
Portfolio after 10yr
$669693703216610.13M
Annual income
$650,996,808,098,825,000,000.00/yr
Blended yield
97.21%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

PEAR
Analyst Ratings
2
Buy
4
Hold
Consensus: Hold
Price Target
$6.50
+22160.3% upside vs current
Range: $5.00 — $8.00
Altman Z
-8.5
Piotroski
4/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+5.6% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PEAR buys
0
PLD buys
0
No recent congressional trades found for PEAR or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPEARPLD
Forward yield6849.32% ✓3.18%
Annual dividend / share$2.00$4.10 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4% ✓
Portfolio after 10y$1339387406433213.75M ✓$6.50M
Annual income after 10y$1,301,993,616,197,644,700,000.00 ✓$5,256,436.18
Total dividends collected$1336879923883212.75M ✓$6.37M
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusHoldBuy
Analyst price target$6.50$136.00 ✓

Year-by-year: PEAR vs PLD ($10,000, DRIP)

YearPEAR PortfolioPEAR Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$695,632$684,931.51$11,255$555.24+$684.4K → PEAR
2$45,273,292$44,528,966.00$13,062$1,018.59+$45.26M → PEAR
3$2,756,897,651$2,708,455,228.62$15,903$1,926.67+$2756.88M → PEAR
4$157,090,270,836$154,140,390,350.12$20,839$3,823.32+$157090.25M → PEAR
5$8,376,539,704,888$8,208,453,115,093.00$30,464$8,166.08+$8376539.67M → PEAR
6$418,028,448,270,623$409,065,550,786,392.40$52,054$19,457.30+$418028448.22M → PEAR
7$19,526,057,962,883,308$19,078,767,523,233,740.00$109,886$54,188.93+$19526057962.77M → PEAR
8$853,759,153,007,212,900$832,866,270,986,927,700.00$304,030$186,451.18+$853759153006.91M → PEAR
9$34,947,467,509,877,550,000$34,033,945,216,159,830,000.00$1,166,125$840,813.32+$34947467509876.38M → PEAR
10$1,339,387,406,433,213,700,000$1,301,993,616,197,644,700,000.00$6,504,190$5,256,436.18+$1339387406433207.25M → PEAR

PEAR vs PLD: Complete Analysis 2026

PEAR — Stock

Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a software-based treatment for chronic insomnia. The company is also developing a pipeline of 14 product candidates focusing on psychiatry, neurology, and outside of central nervous system therapeutic areas, such as gastrointestinal, oncology, and cardiovascular. Pear Therapeutics, Inc. was incorporated in 2013 and is based in Boston, Massachusetts.

Full PEAR Calculator →

PLD — REIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this PEAR vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PEAR vs SCHDPEAR vs JEPIPEAR vs OPEAR vs KOPEAR vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.